David Aubuchon Email

SVP, Finance . Obsidian Therapeutics

Current Roles

Employees:
124
Revenue:
$19.2M
About
Obsidian Therapeutics, founded in 2015, aspires to extend adoptive immunotherapy to every patient with cancer. We do this by building cell therapies with pharmacologic operating systems to provide treating physicians with precise and dynamic control of engineered cells in patients. We create adoptive cell therapies with new functions that are under control of the treating physician using simple, safe, orally-active, marketed drugs. With this unique approach, we can dramatically improve on the current generation of cell therapies. Headquartered in Cambridge, MA, Obsidian has assembled an industry-leading team of experts in immunology, cell therapy, and oncology. We continue to build our team so please check our website (www.obsidiantx.com) often for job opportunities.
Obsidian Therapeutics Address
1030 Massachusetts Ave
Cambridge, MA
United States
Obsidian Therapeutics Email

Past Companies

Obsidian Therapeutics, Inc.Senior Vice President Finance
Sigilon Therapeutics, Inc.Vice President, Head of Finance
Aegerion PharmaceuticalsVice President, Chief Accounting Officer

#1 Startup Dataset

Growth rates, revenue data, direct competitors and contact details.